drugset
drugset / Trial / NCT06810531

Comparison Between Intravenous Ondanosteron and Metclopromide Versus Ondanesteron and Dexamethasone Effects on the Prevention of Postoperative Nausea and Vomiting in Cesarean Section

NCT06810531 ↗

Phase 4 Completed 108 enrolled Aiman Al-Touny
RandomizedParallel-groupTriple-blindPrevention

Summary

The goal of this clinical trial is to prevent intraoperative nausea and vomiting (IONV) and postoperative nausea and vomiting (PONV) through comparing the efficacy of combination ondanosteron plus metclopromide versus ondanesteron plus dexamethasonein in cesarean section . The main objective is to compare the incidence of PONV between the two groups in the first 24 hours. Patients will be randamized allocated into two groups: Group D (Ondanesterone plus dexamethasone) or Group M (ondanesterone plus metoclopramide) .

Timeline

Start
2025-02-05
Primary completion
2025-07-01
Completion
2025-07-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexamethasone Small molecule 8 mg Intravenous
Comparator Metoclopramide Small molecule 10 mg Intravenous
Comparator Ondanesterone Unknown 4 mg Intravenous

Indications

No indication recorded.